Insider · CIK 0001786378

Virgin Herbert

Reports to the SEC for 1 company · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001786378

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-08-09	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+70.2K sh	$1.53	+$107K	254,584
2022-08-09	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+7,916 sh	$10.39	+$82.3K	262,500
2022-08-09	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−70.2K sh	—	—	140,328
2022-08-09	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−7,916 sh	—	—	125,416
2022-03-10	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+9,000 sh	$1.53	+$13.8K	184,407
2022-03-10	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−9,000 sh	—	—	210,505
2022-02-22	VIRVir Biotechnology, Inc.A Award	EVP, Research & CSO	AAward	+70K sh	—	—	175,407
2022-02-22	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+1,375 sh	$1.53	+$2,103.75	176,782
2022-02-22	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−1,375 sh	$30.00	−$41.3K	175,407
2022-02-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−1,375 sh	—	—	219,505
2022-02-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP, Research & CSO	AAward	+70K sh	—	—	70,000
2022-02-17	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−2,293 sh	$31.93	−$73.2K	105,407
2022-02-08	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+1,375 sh	$1.53	+$2,103.75	109,075
2022-02-08	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−1,375 sh	$33.94	−$46.7K	107,700
2022-02-08	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−1,375 sh	—	—	220,880
2022-01-25	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+1,375 sh	$1.53	+$2,103.75	109,075
2022-01-25	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−1,375 sh	$32.46	−$44.6K	107,700
2022-01-25	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−1,375 sh	—	—	222,255
2022-01-11	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+1,375 sh	$1.53	+$2,103.75	109,075
2022-01-11	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−1,375 sh	$35.10	−$48.3K	107,700
2022-01-11	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−1,375 sh	—	—	223,630
2021-12-28	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+1,375 sh	$1.53	+$2,103.75	109,075
2021-12-28	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−1,375 sh	$39.95	−$54.9K	107,700
2021-12-28	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−1,375 sh	—	—	225,005
2021-12-15	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+2,750 sh	$1.53	+$4,207.5	110,450
2021-12-15	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−2,750 sh	$50.00	−$138K	107,700
2021-12-15	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−2,750 sh	—	—	226,380
2021-12-14	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+1,375 sh	$1.53	+$2,103.75	109,075
2021-12-14	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−1,375 sh	$45.88	−$63.1K	107,700
2021-12-14	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−1,375 sh	—	—	229,130
2021-11-30	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+15.1K sh	$1.53	+$23.1K	122,825
2021-11-30	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−1,375 sh	$45.60	−$62.7K	121,450
2021-11-30	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−13.8K sh	$50.00	−$688K	107,700
2021-11-30	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−15.1K sh	—	—	230,505
2021-11-16	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+1,375 sh	$1.53	+$2,103.75	109,075
2021-11-16	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−1,375 sh	$32.67	−$44.9K	107,700
2021-11-16	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−1,375 sh	—	—	245,630
2021-11-02	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+1,375 sh	$1.53	+$2,103.75	109,075
2021-11-02	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−1,375 sh	$36.94	−$50.8K	107,700
2021-11-02	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−1,375 sh	—	—	247,005
2021-10-19	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+1,375 sh	$1.53	+$2,103.75	109,075
2021-10-19	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−1,375 sh	$38.87	−$53.4K	107,700
2021-10-19	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−1,375 sh	—	—	248,380
2021-10-05	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+1,375 sh	$1.53	+$2,103.75	109,075
2021-10-05	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−1,375 sh	$33.75	−$46.4K	107,700
2021-10-05	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−1,375 sh	—	—	249,755
2021-09-22	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+8,000 sh	$1.53	+$12.2K	107,700
2021-09-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	−8,000 sh	—	—	251,130
2021-09-21	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP, Research & CSO	MExercise/Conversion	+4,125 sh	$1.53	+$6,311.25	103,825
2021-09-21	VIRVir Biotechnology, Inc.S Sale	EVP, Research & CSO	SSale	−4,125 sh	$50.00	−$206K	99,700

Recent filings

Accepted (ET)
Aug 104
Virgin Herbert0001209191-22-045230
SEC(opens sec.gov)
Mar 114
Virgin Herbert0001209191-22-018153
SEC(opens sec.gov)
Feb 244
Virgin Herbert0001209191-22-012952
SEC(opens sec.gov)
Feb 224
Virgin Herbert0001209191-22-011755
SEC(opens sec.gov)
Feb 94
Virgin Herbert0001209191-22-008208
SEC(opens sec.gov)
Jan 264
Virgin Herbert0001209191-22-005117
SEC(opens sec.gov)
Jan 134
Virgin Herbert0001209191-22-003175
SEC(opens sec.gov)

Companies

Vir Biotechnology, Inc.EVP, Research & CSOVIR

Address

C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500

SAN FRANCISCO, CA, 94158